Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small molecules in the treatment of COVID-19

5 Dec 2022

Abstract excerpt

Abstract The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to societies and economies. Until now, effective therapeutics against COVID-19 are in high demand. Along with our improved understanding of the structure, function, and pathogenic process of SARS-CoV-2, many small molecules with potential anti-COVID-19 effects have been developed. So far, several antiviral strategies were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to interferon and immune responses
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36464706
DOI: 10.1038/s41392-022-01249-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small molecules in the treatment of COVID-19PMID 36464706Read ↗

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read ↗

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read ↗

Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus InfectionsSemantic proximity Read ↗

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read ↗

Druggable targets and therapeutic development for COVID-19Semantic proximity Read ↗

Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studySemantic proximity Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main proteaseSemantic proximity Read ↗

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read ↗

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

Many small steps towards a COVID-19 drugSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.